BRAF and pachyonychia congenita: Taken together, the high incidence rates of cBRAFV595E underscore the importance of BRAF/MAPK pathway in the pathogenesis of UC and PC and may present dog as a suitable model for BRAF/MAPK pathway-targeted therapy for human UC and PC.